NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) — Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio, demonstrating their ongoing commitment to new advancements in the field of histocompatibility. Immucor announced […]
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user experience without compromising best-in-class performance and accuracy! Currently, there are multiple Next Generation Sequencing (NGS) products and software available to histocompatibility and immunogenetic laboratories. Offering […]
Immucor is in the process of improving our LIFECODES® LifeScreen Deluxe (LMX) to add DP enhanced beads! LMX is a qualitative bead-based immunoassay used to detect IgG antibodies to HLA Class I and Class II molecules. Currently the assay has […]
For all histocompatibility laboratories, Complement-Dependent Cytotoxicity (CDC) testing proves to be time consuming and tedious when evaluating the efforts needed to QC reagents, prepare trays, and perform proficiency testing. Mid-South Transplant Foundation (MSTF) is a private, non-profit organ procurement organization […]
Bridging the Gap: Implementing Multiple Single Antigen Vendors to Ensure Confidence in Results. More labs have been implementing a second vendor for their antibody testing as they continue to see beyond the limits of single antigen testing. In a recent […]
Immucor is a proud partner and gold sponsor of the 18th International HLA & Immunogenetics Workshop, May 2022 in Amsterdam, The Netherlands!
We invite you to participate in these exciting projects that aim to better understand and...